Myeloid sarcoma occurs in 1% -9% of patients with myelogenous leukemia. Spinal epidural myeloid sarcoma is particularly rare, and its treatment has not been established. A 27-year-old woman complained of pain on her left chest, back around the scapula, and neck. Magnetic resonance imaging (MRI) showed a thoracic epidural tumor. One week after her visit, she developed motor weakness of her lower extremities and dysuria, and she was diagnosed with acute myelogenous leukemia (AML) on peripheral blood analysis. The epidural tumor was strongly suspected to be myeloid sarcoma. The paralysis of the lower extremities and bladder dysfunction were not progressive, and chemotherapy and local radiation therapy to the spine were performed. Improvement of paralysis and complete reduction of tumor volume were achieved by the combination of local low-dose radiation therapy and chemotherapy.
Introduction
Myeloid sarcoma, also known as granulocytic sarcoma or chloroma, is an extramedullary localized tumor of immature myeloid cells in patients with acute myeloid leukemia (AML), chronic myeloid leukemia, and myelodysplastic syndrome [1] . It has been reported that myeloid sarcoma occurs in 1% -9% of patients with myelogenous leukemia [2] [3] [4] . The presence of myeloid sarcoma adversely affected the relapse and disease-free survival rates in adult patients with AML [5] . Commonly involved sites of myeloid sarcoma are the skin, soft tissue, bone, periosteum, and lymph nodes [2] [6] [7] . Spinal epidural myeloid sarcoma is not common [7] , and there are several reports of spinal cord compression with paralysis [8] - [14] . The treatment for such patients with neurological symptoms varies, including surgery, radiation therapy, and chemotherapy.
However, the treatment protocol has not been established. A case of AML, which showed an acute onset of myelopathy due to spinal epidural myeloid sarcoma at the thoracic spine and was treated with local low-dose radiation therapy and chemotherapy, is presented.
Case Report
A 27-year-old woman complained of a 2-month history of pain of her left chest, back around the scapula, and neck. Magnetic resonance imaging (MRI) ordered by a primary care physician showed an epidural tumor at T3-5. She developed a motor weakness of her lower extremities and dysuria one week after the MRI.
She was referred to a general hospital, and leukemia was suspected based on a complete blood count. She was immediately referred to our hospital and admitted to the hematology department. Although she could walk with a cane, she had paresthesia from three fingers below the sternoclavicular joints and motor weakness of the extensor hallucis longus muscles (manual muscle test grade 4/5) with hyperreflexia of both lower extremities, positive ankle clonus, and dysuria.
The white blood cell count was 9000/μl (blast cells accounted for 23%), the hemoglobin (Hb) level was 8.6 g/dl, and the platelet count was 40,000 cells/μl. MRI showed a left dorsal epidural tumor at T3-T5 with iso-intensity on T1 and T2-weighted signal images (Figure 1 tumor at the T3-T5 level. There was no mechanical scalloping effect on the surrounding bone (not shown). Since the hematologic study from peripheral blood resulted in the diagnosis of AML and she had been healthy, the epidural tumor was strongly suspected to be myeloid sarcoma.
Followed by the careful interview of her history of paralysis and physical examination, we have evaluated that the paralysis of the lower extremities and bladder dysfunction were not progressive. Then, intravenous methylprednisolone pulse treatment and local radiation therapy to the spine were started on the day of admission to our hospital instead of emergent surgical decompression.
On the day following irradiation, the subjective symptoms of paralysis and paresthesia were improved. On the third day after initiating irradiation, the AML type was diagnosed as M2 by the French-American-British (FAB) Classification with a blast ratio of 70% by bone marrow aspiration. Then, remission induction therapy with 5 days of daunorubicin and 7 days of cytarabine (DNR/Ara-C) was also started. On the fifth day, MRI showed that the dorsal epidural tumor had va One month after final chemotherapy, she underwent allogeneic stem cell transplantation. Two years post-irradiation, no recurrence of neurological deficit or paralysis has been observed.
Discussion
There have been several case reports and small case series of spinal myeloid sarcoma with spinal cord compression causing paralysis [8] - [14] . The majority of the patients with neurological symptoms were treated with surgical decompression combined with chemotherapy [8] [10] [11] [14] , radiation therapy [9] , and both radiation and chemotherapy [12] . However, no specific guidelines on the management of myeloid sarcoma associated with AML are currently available.
Surgical decompression followed by radiotherapy has been reported to be more effective than radiotherapy alone in terms of pain control and ambulation for spinal cord compression by metastatic disease [15] . However, this study excluded patients with radiosensitive tumors such as leukemia and lymphoma.
Radiation therapy for spinal myeloid sarcoma has been reported to be effective [7] [16]. The tumor volume in all patients regressed completely or partially after radiation therapy [16] . Motor function of the lower extremity improved gradually with radiation [9] . As radiation therapy for local control of myeloid sarcoma, Bakst et al. recommended a protocol for a localized mass with irradiation of 24 Gy in 12 divided doses [7] . In the current case, compression of the spinal cord due to the mass of the vertebral canal was observed on MRI, but paralysis and bladder dysfunction were not severe and progressive. Therefore, local radiation therapy and chemotherapy for remission induction therapy were chosen. The size of the epidural mass was significantly decreased in a short time, and the lower extremity symptoms improved. Considering the possibility of total body irradiation for remission induction and the spinal cord tolerable dose at recurrence, radiation therapy was stopped at a total dose of 21 Gy on the seventh day of irradiation.
Myeloid sarcoma is a local lesion of leukemia, so remission-induction chemotherapy is considered necessary for radical treatment. Due to the high rate of progression to acute leukemia, especially in patients who are treated with localized methods, conventional systemic treatments are recommended for the treatment of isolated myeloid sarcoma presenting concomitantly with AML [17] [18]. Since the current case was diagnosed as AML on bone marrow aspiration, it was essential to give chemotherapy concurrently with localized radiotherapy.
A limitation of this case report was that there was no pathological evidence of the local lesion by excisional biopsy. However, the use of radiation therapy and adjuvant chemotherapy for the lesion relieved the neurological symptoms and reduced the size of the mass. Early and precise diagnosis with imaging studies followed by analyses of peripheral blood and bone marrow aspiration led to the 
Conclusion
The improvement of paralysis and complete reduction of tumor volume was achieved by the combination of local low-dose radiation therapy and chemotherapy for a case of spinal epidural myeloid sarcoma in an AML patient. Chemotherapy based on AML treatment is recommended for myeloid sarcoma, but it is also reported that low-dose radiation therapy is effective for local control.
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